Targeted disruption of MCPIP1/Zc3h12a results in fatal inflammatory disease.
(1/18)
(+info)
Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis.
(2/18)
(+info)
Role of complement in host-microbe homeostasis of the periodontium.
(3/18)
(+info)
High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.
(4/18)
(+info)
Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.
(5/18)
(+info)
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.
(6/18)
(+info)
Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection.
(7/18)
(+info)
Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease.
(8/18)
(+info)